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THE DURATION OF IMMUNITY TO TETANUS*
HENRY W. BAIRD, III
It has been well established that immunity to tetanus in man
follows a series of injections with plain or alum-precipitated toxoid.
1, 2, 4, 7, 11, 15, 16, 28 Because this method has been in use but for a com-
paratively short time, the duration of immunity and the response to a
single "booster" injection four or more years after the initial series
appear to merit further study. This paper reviews the development and
use of toxoid and reports the antitoxin level and response of individuals
who had their last injection more than four years previously.
In 1924, Descombey8 described the production of a tetanus toxoid
by the technique of Ramon,24' 25, 26, 27 and the next year Ramon pub-
lished the first of a series of papers concerning its manufacture and pos-
sible use. This work stemmed from the development of a useful toxoid
from diphtheria toxin. At first the tetanus toxoid was likewise prepared
by the addition of formalin to the toxin. Later, precipitation of the
toxoid by alum was found to increase the antitoxin response.'
The amount of circulating antitoxin necessary to protect man has
been estimated by several investigators. By analogy with results obtained
from experimental animals given tetanus infection following skin
abrasions, Cowles7 suggested that in man a fairly certain protection
would be given by 0.1 to 0.2 of a unit per cubic centimeter of serum.
Bergey and Etris2 set the minimum amount of antitoxin in serum at 0.1
unit, which is the antitoxin level four days after the administration of
1500 units of antitoxin.9 Since the publication of these figures, other
investigators have used them in discussing their results.
Bergey,' in 1934, suggested that immunization might be carried out
by two injections of 1 cc. oftoxoid, the second beinggiven three months
after the first. A third injection of 1 cc. was to begiven following injury.
The result of such a procedure, as shown by data obtained by Bergey
andEtris2 fromthirtyindividuals, wasthatthe levelsof antitoxin reached
in the sera were low in comparison to results obtained when injections
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were given more frequently.3 In France and in pediatric medicine in
this country, tetanus toxoid has been combined with diphtheria toxoid
with some success.12' 23
Active immunization against tetanus for members of the armed
forces was suggested by Sneath29 and others before the outbreak of the
second World War. The procedure used by the United States Army
during the war underwent some modification as the result of further
investigation.17 The original plan called for the immunization of every
soldier at the time of induction, with three injections one week apart, a
single injection every year, a single injection before going to a combat
area (if the individual had not been given a booster dose within the
previous sixmonths), and asingle injection on injury. Bythe conclusion
of the war only the initial series and the single injection on injury were
given in somecases, though considerable variation in routine took place.
In the British Army the routine differed in that initial immunization
until 1941 consisted oftwo injections, becauseofthe shortage of toxoid.4
Instead of using toxoid at the time of injury, 3000 units of antitoxin
were injected. Later the initial series was increased to three injections of
1 cc. each, but the use of antitoxin instead of toxoid was maintained.
The results of these procedures in the British and in the American
Armies have beenpublishedby Boyd4 andby Long.17Of the twelvecases
of tetanus known to have developed in the Army of the United States,
half of the men had not been given the basic immunization. Of the six
which had no kind of immunization there were two fatalities. One of
the two which had been given the basic but not the injury injection
terminated fatally, as did two of the four cases which had both the basic
and the injury injections. Of the 103 cases of tetanus collected by Boyd
from reports of the British Army in the European and African cam-
paigns, twenty-two (eleven fatalities) were considered to have been
adequately protected, sixty-two (twenty-nine fatalities) were considered
unprotected, and nineteen (eight fatalities) were doubtful or incom-
plete. No deaths are known to have occurred in those receiving two
initial injections plus two or more annual booster doses.
Complications to the injection of toxoid in the Army of the United
States were placed in two main categories by Long.'7 The first type was
similar to the soreness at the site of injection, headache, general malaise,
occasional chills, and fever after typhoid inoculation. The second type
of reaction was characterized by the early appearance, usually within
thirty minutes after the injection, of flushing and itching of the skin,
perhaps urticarial eruptions, occasional edema of the lips and eyelids,
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and, rarely, edema of the glottis and respiratory difficulty. These compli-
cations were decreased markedly, from 63 per 100,000 or less, by using
toxoids that did not contain Witte's or Berna's peptone.6 '" Complica-
tions to injection of toxoid are not reported by Boyd, but similar circum-
stances seem to have prevailed.5 20, 0 Clearly, these difficulties are small
in comparison to the dangers and time sometimes involved in the ad-
ministration of antitoxin.
That an adequate rise in titer follows a booster injection of toxoid
three years after basic immunization has been shown by several investi-
gators.4 18, 23 For longer periods of time, fewer data have beenpublished.
Long"7 finds that the response is adequate for both the three- to four-year
period and the four- to five-year period. The seven cases he reports show
an adequate response in seven days, but the questions might well be
asked whether this is a large enough sample and whether a shorter
period might not more nearly represent the circumstances for which a
rise in titer might be necessary in time of injury. Hence the presentwork
was undertaken.
Method
The titrations of antitoxin level reported in this paper were carried out by a
method which utilizes mice.'3 14 A 20-gm. mouse was injected subcutaneously
with a solution containing 0.5 cc. of the serum of the individual being tested and
0.5 cc. of toxin (Lederle), diluted to the appropriate strength, which had been
mixed and allowed tostand for thirty minutes. The toxin was prepared by making
a stock solution of 200 mg. of tetanus toxin (the test dose being 0.00004 gm. per
0.5 ml. equals 0.1 unit) in 50 cc. of glycerol. Dilutions from stock were made
with broth. The strengths used were 1.0 unit (1 cc. of stock plus 9 cc. of broth),
3.16 units (1 cc. of stock plus 2.16 cc. of broth), and 0.01 unit, 0.0316 unit,
and 0.316 unit prepared in a similar manner. Death of the mouse within four
days was considered a positive test. An individual whose serum protected mice
at a level of 0.0316, 0.1, and 0.316 but not at 1.0 and 3.0 units, as evidenced by
the fact that the mice died within four days in only the latter two cases, is re-
ported as having a level of 0.316 unit of tetanus antitoxin. The serums, many of
which were obtained by the Department of Health of Yale University, were
drawn immediately before a booster dose of 0.5 cc. of alum-precipitated toxoid
was administered. Six subjects were tested at five and at seven days, and the
serums of the remaining seventeen individuals were obtained at five days only.
All of the individuals studied were males in the 20 to 30 age group who had
served in the armed forces.
Results
Considerable variation was found in the sera tested. In every case
the sera were found to have at least 0.1 unit of antitoxin five days after
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SUMMARY OF RESULTS-IMMUNITY TO TETANUS
Elapsed time be-
Sub- tween basic im- Elapsed time between
ject munization and last booster dose and Initial After5 After7
No. present titration present titration level days days
Years Months Years Months
1 3 10 .0316 .316
2 5 0 3 11 .1 1.0
3 5 0 3 11 1.0 10.0
4 5 0 4 0 .316 .316
5 4 1 .01 .1
6 4 1 .316 1.0 3.16
7 5 3 5 0 - .316
8 4 2 .01 .1 .316
9 4 3 .316 1.0
10 4 4 .1 .316
11 5 11 4 7 .0316 .1 -
12 4 8 .0316 1.0 -
13 4 8 .0316 .316
14 4 10 .1 .316 1.0
15 5 0* .0316
16 5 0 1.0 3.16 -
17 5 1 .0316 .316
18 5 1 .1 .316 -
19 5 1 .0316 .316 1.
20 5 2 .1 .316 1.
21 7 4 5 2 3.16 10.0
22 5 4 .0316 .1 .316
23 6 2 .1 1.0 -
After titrations had been completed, investigation of previous inoculations showed that only one
initial toxoid injection 5 years before test and perhaps one more injection 4 11/12 years before test
had been given.
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the booster injection. The six serums tested at seven days showed a con-
tinuance of the rise. In the one case where no residual titer was found
and the response was 0.0316 unit, closer investigation showed that the
initial immunization had not been adequate. Nine others did not show
the level considered as a minimum for protection before the booster was
given. See Table and Chart.
Comment
Before considering the duration of the immunityproducedbytetanus
toxoid, itmaybepointed outthatconsiderable variation in the protective
qualities of the various market preparations has been described.10 Ad-
ministration of the toxoid in individuals 4, 5, and perhaps 6 years after
initial immunization or after the last booster appears to give adequate
protection in five days, using as a minimum standard 0.1 unit. How
adequate this level may be, since it is a value obtained only on indirect
evidence, remains speculative at this time. No differences in response
because of sex were noted by Peshkin;23 no mention of such differences
was found in reviewing the literature. Peshkin noted that in children
thetiter was higher and more lastingwhen a booster shotwas given four
years after initial immunization than itwas whenthis stimulus was given
three to fifteen months after the basic injection.
In cases where increased toxin production seems likely because ofthe
nature of the wound, a booster given immediately after injury might not
be sufficient. While the data reported in this paper would seem to indi-
cate, as do the reports of Long and Sartwell17 and of Peshkin,21 22, 23
that the booster stimulation of antitoxin may be adequate for a longer
period of time than is generally recognized, statistical analysis of the
relatively small amountof data thus far reported is not rewarding.
Conclusion
Twenty-three individuals who were given basic tetanus immuniza-
tion with toxcoid or who were given their last booster four or more years
ago were tested before and five days after an injection of 0.5 cc. alum-
precipitated toxoid. Six were also tested at seven days. Results indicate
that by present standards an adequate antitoxin response developed
within fivedays after injection.
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